EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

YAP1::KMT2A ‐Rearranged Sarcoma: Report of a New Case With Unusual Morphology and Immunohistochemical Features

Caterina Fumagalli iD, Ruth Orellana, Sílvia Bagué, Malena Ferré, Allan Gonzalez, Lluis Catasús, Jaume Llauger, Ana Peiró, Paul Zamora Alarcón, Katarina Majercakova, Raúl Terés, Marie Karanian-Philippe iD und 2 weitere

Genes, Chromosomes and Cancer · 2025

DOI: 10.1002/gcc.70059 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, Chromosomes and Cancer, 2025. Verfasst von Caterina Fumagalli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Hauptthemen laut MEDLINE: Sarcoma, Histone-Lysine N-Methyltransferase, Transcription Factors, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recurrent KMT2A and YAP1 related fusions have recently been reported in various mesenchymal neoplasms of different histogenesis. First, YAP1::KMT2A fusions have been described in a subset of MUC4‐negative sclerosing epithelioid fibrosarcomas (SEF), while VIM::KMT2A fusions in a handful of cases associated with an undifferentiated spindle cell phenotype lacking stromal hyalinization. On the other hand, YAP1 gene rearrangements have been reported in a wide spectrum of sarcomas, including vascular neoplasms such as epithelioid hemangioendothelioma (EHE). Despite these molecular advances, occasional challenges in classification may occur even if the pathognomonic fusion is identified. In this study, we report such a case of a soft tissue sarcoma displaying an unusual morphology and immunoprofile, which remained unclassified even after a YAP1::KMT2A fusion was detected. The lesion occurred in the left leg of a 65‐year‐old female and microscopically closely resembled a SEF, with epithelioid morphology organized in cords, nests, and sheets in a heavy hyalinized background. Focally, the cells showed cytoplasmic vacuoles with eosinophilic material, reminiscent of the “blisters cells” seen in EHE. Moreover, by immunohistochemistry (IHC), the tumor showed diffuse reactivity for vascular markers, including ERG, CD31, CD34, and D2‐40, as well as for TFE3, while being negative for MUC4, CAMTA1, smooth‐muscle actin, desmin, S100 and keratins. Targeted RNA sequencing revealed a YAP1::KMT2A fusion. Based on this molecular result and the conflicting morphologic and IHC findings, a definitive distinction between a MUC4‐negative SEF and an EHE could not been established. To further subclassify the lesion, subsequent clustering analysis using RNAseq signature was performed against a vast group of sarcoma types on the same array. Results showed that the tumor was in close proximity to the SEF group, admixed together with the other YAP1::KMT2A MUC4 negative SEF sarcomas. This case is highly instructive, as it shows another application of RNA sequencing in clinical practice when discordant or uncertain results between pathologic findings and fusion type may occur. Indeed, RNAseq signature could help, in this context, to better classify the tumor as a YAP1::KMT2A sarcoma instead of a vascular tumor. Larger series are needed to evaluate the pathogenesis of these tumors and the relevance of vascular markers expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaHistone-Lysine N-MethyltransferaseTranscription FactorsAdaptor Proteins, Signal TransducingSoft Tissue NeoplasmsHumansYAP-Signaling ProteinsFemaleAgedGene RearrangementBiomarkers, TumorOncogene Proteins, FusionImmunohistochemistryMyeloid-Lymphoid Leukemia Protein

Stichwörter der Autor:innen

KMT2A::YAP1 fusionsarcomasclerosing epithelioid fibrosarcoma

Substanzen

YAP-Signaling ProteinsYAP1 protein, humanKMT2A protein, humanHistone-Lysine N-MethyltransferaseTranscription FactorsAdaptor Proteins, Signal TransducingBiomarkers, TumorOncogene Proteins, FusionMyeloid-Lymphoid Leukemia Protein

Autor:innen und Institutionen

  • Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Department of Radiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Department of Traumatology and Orthopedics, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Department of Plastic and Reconstructive Surgery, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Department of Radiation Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Department of Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

ORCID-Profile: Caterina Fumagalli, Marie Karanian-Philippe, Franck Tirode, Cristina R Antonescu

Förderung

  • NCI NIH HHS
  • National Institute of Health

Zitieren

APA

Fumagalli, C., Orellana, R., Bagué, S., Ferré, M., Gonzalez, A., Catasús, L., Llauger, J., Peiró, A., Alarcón, P. Z., Majercakova, K., Terés, R., Karanian-Philippe, M., Tirode, F., & Antonescu, C. R. (2025). YAP1::KMT2A ‐Rearranged Sarcoma: Report of a New Case With Unusual Morphology and Immunohistochemical Features. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.70059

Vancouver

Fumagalli C, Orellana R, Bagué S, Ferré M, Gonzalez A, Catasús L, et al. YAP1::KMT2A ‐Rearranged Sarcoma: Report of a New Case With Unusual Morphology and Immunohistochemical Features. Genes, Chromosomes and Cancer. 2025. doi:10.1002/gcc.70059

BibTeX
@article{Fumagalli2025,
  author = {Fumagalli, Caterina and Orellana, Ruth and Bagué, Sílvia and Ferré, Malena and Gonzalez, Allan and Catasús, Lluis and Llauger, Jaume and Peiró, Ana and Alarcón, Paul Zamora and Majercakova, Katarina and Terés, Raúl and Karanian-Philippe, Marie and Tirode, Franck and Antonescu, Cristina R},
  title = {YAP1::KMT2A ‐Rearranged Sarcoma: Report of a New Case With Unusual Morphology and Immunohistochemical Features},
  journal = {Genes, Chromosomes and Cancer},
  year = {2025},
  doi = {10.1002/gcc.70059}
}
Kostenlos starten →